Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTXBiotechnology
+$0.10 today
- Market cap
- $980.14M
- Beta
- 0.00
Volume 0.68M
Average 0.41M
SPTX Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Common Stock history
Currency unavailable · from the balance sheet
No Common Stock data reported for this period type.
Common Stock vs competitors
How SPTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.55M USD | +0.0% | +6.0% | 0.6% | |
| Mar 2026 | $60K USD | +1.7% | +1.2% | 0.0% | |
RAPPRapport Therapeutics, Inc. Common Stock | Mar 2026 | $48K USD | +29.7% | +15.7% | 0.0% |
CTNMContineum Therapeutics, Inc. Class A Common Stock | Mar 2026 | $37K USD | +42.3% | +45.5% | 0.0% |
NMRANeumora Therapeutics, Inc. Common Stock | Mar 2026 | $18K USD | +12.5% | +78.3% | 0.0% |
| Mar 2026 | $5K USD | — | — | 0.0% | |
LBRXLB Pharmaceuticals Inc Common Stock | Mar 2026 | $3K USD | +200.0% | +44.2% | 0.0% |
SPTXSeaport Therapeutics, Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding SPTX) | — | +21.1% | +30.0% | 0.0% | |
Competitors are the stored peer set for SPTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Seaport Therapeutics, Inc. Common Stock
NASDAQ:SPTX
Intrinsic Alpha fair value
Locked
Current Price
$18.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.